AstraZeneca Aktie
130,40
EUR
+2,30
EUR
+1,80
%
109,38
GBP
+0,94
GBP
+0,87
%
Werbung
AstraZeneca Aktie Analyse
08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
31.08.17 | AstraZeneca Neutral | UBS AG | |
24.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
09.08.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
01.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
01.08.17 | AstraZeneca Neutral | UBS AG | |
31.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
Werbung
|
|||
28.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
28.07.17 | AstraZeneca neutral | Credit Suisse Group | |
27.07.17 | AstraZeneca Hold | S&P Capital IQ | |
27.07.17 | AstraZeneca Neutral | UBS AG | |
21.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
13.07.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
12.07.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
27.06.17 | AstraZeneca Neutral | UBS AG | |
16.06.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
24.05.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
12.05.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
28.04.17 | AstraZeneca market-perform | Bernstein Research | |
27.04.17 | AstraZeneca Neutral | UBS AG | |
21.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
18.04.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
10.04.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
05.04.17 | AstraZeneca Neutral | UBS AG | |
15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
20.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
07.02.17 | AstraZeneca Hold | HSBC | |
07.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
03.02.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
26.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
04.01.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
12.12.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
28.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
02.11.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
26.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
19.10.16 | AstraZeneca market-perform | Bernstein Research | |
10.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
05.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
04.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
14.09.16 | AstraZeneca Neutral | BNP PARIBAS | |
06.09.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
11.08.16 | AstraZeneca Hold | HSBC | |
10.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
09.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
08.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
08.08.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
04.08.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
02.08.16 | AstraZeneca Hold | HSBC |
Werbung